VAERS Explorer
Back to explore

Report #2844843

Received Jun 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NY
Recovered
Unknown
Vaccinated
May 19, 2025
Onset
May 19, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKY017063—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No symptoms reported; Nurse called to report TE for VARIVAX and reports the VARIVAX was inadvertently administered; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-May-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) for prophylaxis (lot #Y017063 was verified to be a valid number, expiration date: 11-Oct-2026) (dose, scheme, route of administration, formulation and injection site were not reported) reconstituted with sterile diluent (BAXTER STERILE DILUENT) (dose, frequency, route of administration, expiration date and lot # were not reported). The vaccine underwent a temperature excursion of -11.5 Celsius degree for 24 minutes (product storage error). No symptoms were reported (no adverse event).

Other medications

Sterile diluent